LIP
TMO icon

Liontrust Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Liontrust Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$128M Sell
260,666
-104,298
-29% -$56.6M 2.19% 7
2025
Q4 		$211M Sell
364,964
-84,307
-19% -$47.7M 3.14% 4
2025
Q3 		$218M Sell
449,271
-17,191
-4% -$8M 3.18% 5
2025
Q2 		$189M Sell
466,462
-23,928
-5% -$10M 2.71% 6
2025
Q1 		$244M Buy
490,390
+1,693
+0.3% +$917K 3.81% 2
2024
Q4 		$254M Buy
488,697
+81,911
+20% +$45M 3.69% 2
2024
Q3 		$225M Hold
406,786
– – 3.2% 5
2024
Q2 		$225M Sell
406,786
-11,534
-3% -$6.61M 3.2% 5
2024
Q1 		$243M Sell
418,320
-41,134
-9% -$23.1M 3.39% 3
2023
Q4 		$244M Buy
459,454
+50,260
+12% +$24.3M 3.54% 3
2023
Q3 		$207M Buy
409,194
+14,132
+4% +$7.53M 3.31% 5
2023
Q2 		$206M Buy
395,062
+20,824
+6% +$11.2M 2.97% 7
2023
Q1 		$216M Buy
374,238
+27,324
+8% +$15.4M 3.16% 4
2022
Q4 		$191M Sell
346,914
-29,900
-8% -$15.8M 3.34% 5
2022
Q3 		$191M Sell
376,814
-64,800
-15% -$36.3M 3.06% 5
2022
Q2 		$240M Sell
441,614
-53,800
-11% -$29.6M 3.38% 6
2022
Q1 		$293M Buy
495,414
+4,500
+0.9% +$2.59M 3.82% 3
2021
Q4 		$328M Sell
490,914
-54,700
-10% -$34.2M 3.9% 3
2021
Q3 		$312M Buy
+545,614
New +$299M 4.31% 3
2020
Q4 		$148M Buy
+317,514
New +$149M 2.98% 8

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Liontrust Investment Partners's TMO Position: Q1 2026 in Review

Liontrust Investment Partners reduced its Thermo Fisher Scientific (TMO) stake by 29% in Q1 2026, selling an estimated $56.6M and leaving 260,666 shares worth $128M. The position accounts for 2.19% of the portfolio, ranked #7.

Liontrust Investment Partners first reported a position in TMO in Q4 2020 and has held it in 20 quarters since. The position peaked at $328M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Liontrust Investment Partners held 260,666 shares of Thermo Fisher Scientific worth $128M as of Q1 2026.
  • Liontrust Investment Partners sold 104,298 Thermo Fisher Scientific shares in Q1 2026, an estimated $56.6M.
  • Thermo Fisher Scientific made up 2.19% of Liontrust Investment Partners's portfolio in Q1 2026, its #7 holding.
  • Liontrust Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 20 quarters since.
  • Liontrust Investment Partners's Thermo Fisher Scientific position peaked at $328M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Liontrust Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.